|Bid||2.5960 x N/A|
|Ask||2.8600 x N/A|
|Day's Range||2.7900 - 2.7900|
|52 Week Range||2.3480 - 17.0452|
|Beta (5Y Monthly)||0.59|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) CEO and Chairman, Raza Bokhari speaks about the company's lead Compound, PEA, to treat COVID-19.If you cannot view the video above, please visit:https://www.b-tv.com/fsd-pharma-compound-to-treat-covid-19-ceo-clip-90sec/FSD Pharma will air on BIZTV throughout the month of August 2020, throughout the day and evenings.FSD Pharma Inc. (CSE: HUGE) (NASDAQ: HUGE) fsdpharma.comAbout CEO Clips:CEO Clips is the largest library of publicly traded company CEO ...
TORONTO, ON / ACCESSWIRE / July 31, 2020 / FSD Pharma Inc.
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced that it has notified Health Canada of the Company’s decision to forfeit the licenses of its wholly-owned subsidiary, FV Pharma, Inc. ("FV Pharma") and suspend all activities by FV Pharma within 30 days of the notification date. FSD Pharma has begun the process of liquidating all FV Pharma assets, including the sale of the Company’s cannabis production facility in Cobourg, Ontario.